Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Short term Debt: 2021-2025

Historic Short term Debt for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Sep 2025 value amounting to $20.0 million.

  • Harmony Biosciences Holdings' Short term Debt rose 33.33% to $20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year increase of 33.33%. This contributed to the annual value of $16.2 million for FY2024, which is 8.33% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Short term Debt stood at $20.0 million, which was up 6.67% from $18.8 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Short term Debt ranged from a high of $20.0 million in Q3 2025 and a low of $2.0 million during Q3 2021.
  • Its 3-year average for Short term Debt is $15.0 million, with a median of $15.0 million in 2024.
  • Data for Harmony Biosciences Holdings' Short term Debt shows a peak YoY spiked of 650.00% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows Harmony Biosciences Holdings' Short term Debt stood at $2.0 million in 2021, then remained steady at $2.0 million in 2022, then skyrocketed by 650.00% to $15.0 million in 2023, then grew by 8.33% to $16.2 million in 2024, then soared by 33.33% to $20.0 million in 2025.
  • Its Short term Debt was $20.0 million in Q3 2025, compared to $18.8 million in Q2 2025 and $17.5 million in Q1 2025.